Oxymorphone Hydrochloride

盐酸羟吗啡酮

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOxymorphone Hydrochloride
Drug Alias Nameoximorfona羟吗啡酮oxymorphonumoxymorphoneOpana ER +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors agonists
TargetsOpioid receptors
Therapy Area/IndicationsChronic PainLow Back PainAcute Pain +[8] 
Global Approved IndicationsPain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1959/01/01
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesEndo International Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Canada CoSandozEndo Pharmaceuticals Inc +[4] 
Active IndicationsPain
Inactive IndicationsChronic PainLow Back PainAcute Pain +[7] 

Other Information

ATC CodeN02AA
Related LinksWikipediaDrugBankKEGG